Skip to content

GlobalRPh Renal Dosing Masterv6.8

Clinical interpretation | Version 6.8

Find the difference.
Keep the context.

Search documented disagreements and product cautions across the local library. Compare complete source versions on the drug page before choosing a regimen.

Search source differences

451 notes across 412 drug/product records.

How to interpret these notes

Generic name, brand, source or issueType of differenceAdded in v6.8

Clear filters Export all filtered notes

Search medication names and documented issues only. Do not enter patient information. This directory submits search filters to the server; the within-drug text finder remains a separate local feature.

A difference is not always a contradiction

Compare indication, formulation, route, population, renal method, dialysis conditions and source date. A safety update or source-quality failure is not an alternative dose. These notes are not independent clinical approval, and sources are not ranked or averaged.

451 matching notes. Showing 225-240; page 15 of 29.

formulation scope

Letermovir (PREVYMIS)

PREVYMIS: IV-vehicle monitoring differs from active-drug dose adjustment

The IV hydroxypropylbetadex issue has its own renal threshold. The selected active-drug guidance also leaves an exact-boundary gap at 10.

What to reconcile

Check route, formulation, age-appropriate renal assessment and the exact boundary; do not convert vehicle monitoring into an invented dose reduction.

1 source identities and dates

GlobalRPh RX List - PREVYMIS

GlobalRPh-hosted RX List | Source revision: Source revision date not established in selected retrieval.
Letermovir - PREVYMIS renal and intravenous-vehicle supplement; selected renal passages, not a complete prescribing monograph.

Read this stored source

Source-specific interpretation; independent clinician adjudication pending. Added: v5.0.

Open / share source review Open drug and compare sources

formulation scope

Levetiracetam - ELEPSIA XR

ELEPSIA XR: same ingredient does not mean the same renal table

ELEPSIA XR has its own tablet strengths and restricted renal table. The selected source directs use of other levetiracetam products in moderate/severe impairment and immediate-release tablets in dialysis.

What to reconcile

Match the exact product and BSA-adjusted CrCl method; do not import the KEPPRA XR lower-dose bands into ELEPSIA XR.

1 source identities and dates

GlobalRPh RX List - ELEPSIA XR

GlobalRPh-hosted RX List | Source revision: Source revision date not established in selected retrieval.
ELEPSIA XR extended-release tablets; selected adult renal table. Not a substitute for other levetiracetam products.

Read this stored source

Source-specific interpretation; independent clinician adjudication pending. Added: v4.5.

Open / share source review Open drug and compare sources Levetiracetam - related, not interchangeable Levetiracetam extended-release tablets (KEPPRA XR) - related, not interchangeable Levetiracetam injection (KEPPRA) - related, not interchangeable

product or method difference

Levetiracetam extended-release tablets (KEPPRA XR)

KEPPRA renal measure, overlapping boundary and release form

The source computes Cockcroft-Gault clearance and then adjusts it to 1.73 m2 BSA. Its 30-50 and 50-80 bands overlap at exactly 50. XR directs dialysis patients to immediate-release KEPPRA; the injection source has a separate dialysis schedule.

What to reconcile

Check the indexed CrCl units and clarify the endpoint. Do not substitute laboratory eGFR automatically or attach an injection post-HD supplement to XR.

1 source identities and dates

GlobalRPh RX List - KEPPRA XR

GlobalRPh-hosted RX List | Source revision: Source revision date not established in selected retrieval.
KEPPRA XR adult renal table; not the immediate-release or injection regimen.

Read this stored source

Source-specific interpretation; independent clinician adjudication pending. Added: v4.2.

Open / share source review Open drug and compare sources Levetiracetam injection (KEPPRA) - related, not interchangeable Levetiracetam - related, not interchangeable

product or method difference

Levetiracetam injection (KEPPRA)

KEPPRA renal measure, overlapping boundary and release form

The source computes Cockcroft-Gault clearance and then adjusts it to 1.73 m2 BSA. Its 30-50 and 50-80 bands overlap at exactly 50. XR directs dialysis patients to immediate-release KEPPRA; the injection source has a separate dialysis schedule.

What to reconcile

Check the indexed CrCl units and clarify the endpoint. Do not substitute laboratory eGFR automatically or attach an injection post-HD supplement to XR.

1 source identities and dates

GlobalRPh RX List - KEPPRA Injection

GlobalRPh-hosted RX List | Source revision: April 2016
KEPPRA injection adult renal table; pediatric renal dosing is not established by this section.

Read this stored source

Source-specific interpretation; independent clinician adjudication pending. Added: v4.2.

Open / share source review Open drug and compare sources Levetiracetam extended-release tablets (KEPPRA XR) - related, not interchangeable Levetiracetam - related, not interchangeable

route indication and dialysis timing

Levocarnitine - CARNITOR intravenous injection

The post-HD regimen is indication-specific replacement therapy

The mirror uses dry body weight and trough-guided adjustment for injectable replacement.

What to reconcile

Confirm deficiency and the exact current injection label. Do not transfer this regimen to oral formulations.

1 source identities and dates

GlobalRPh RX List - CARNITOR injection

GlobalRPh-hosted RX List | Source revision: 4/2018
CARNITOR intravenous levocarnitine for dialysis-associated carnitine deficiency; match indication, route and dry body weight.

Read this stored source

Source-specific interpretation; independent clinician adjudication pending. Added: v5.8.

Open / share source review Open drug and compare sources Levocarnitine - CARNITOR oral formulations - related, not interchangeable

route specific metabolite caution

Levocarnitine - CARNITOR oral formulations

Oral metabolite concerns are not resolved by an injectable HD regimen

Oral renal evidence and the injectable replacement regimen address different routes and contexts.

What to reconcile

Keep oral and IV entries separate; do not infer oral safety or equivalence from the injection schedule.

1 source identities and dates

GlobalRPh RX List - CARNITOR oral

GlobalRPh-hosted RX List | Source revision: 6/2023
CARNITOR oral tablets and solutions, including sugar-free solution; not the injectable hemodialysis product.

Read this stored source

Source-specific interpretation; independent clinician adjudication pending. Added: v5.8.

Open / share source review Open drug and compare sources Levocarnitine - CARNITOR intravenous injection - related, not interchangeable

ambiguous threshold

Levocetirizine

Printed CrCl bands overlap at 30 and 50

The RX renal bands share their 30 and 50 mL/min endpoints. Two printed ranges therefore touch the same exact boundary.

What to reconcile

Do not let software choose an interval at an ambiguous endpoint. Reconcile the exact product label and local policy; retain the pediatric and dialysis restrictions.

1 source identities and dates

GlobalRPh RX List - XYZAL

GlobalRPh-hosted RX List | Source revision: Source revision date not established in selected retrieval.
XYZAL oral levocetirizine; numeric adjustment applies only from age 12.

Read this stored source

Source-specific interpretation; independent clinician adjudication pending. Added: v3.5.

Open / share source review Open drug and compare sources

source scope and renal guidance

Levofloxacin

Select the usual regimen before the renal row

The 750, 500 and 250 mg renal paths differ. The 250 mg row has a specific uncomplicated-UTI exception and lacks dialysis adjustment information.

What to reconcile

Retain indication, usual dose, loading dose and maintenance interval together.

1 source identities and dates

GlobalRPh RX List - LEVAQUIN

GlobalRPh-hosted RX List | Source revision: Revision not established in selected retrieval
Selected LEVAQUIN adult oral-tablet renal table; not pediatric or automatically an IV administration instruction.

Read this stored source

Source-specific interpretation; independent clinician adjudication pending. Added: v6.1.

Open / share source review Open drug and compare sources

setting specific

Linezolid

Label guidance versus selected expert dose reduction

The label does not require routine renal reduction. UCSF describes a selected strategy for stable patients with CrCl below 30 and an anticipated course longer than 10 days, after the initial 72 hours.

What to reconcile

Do not apply a reduced regimen universally. Retain the clinical-stability, duration, monitoring and specialist qualifiers.

2 source identities and dates

GlobalRPh RX List - Zyvox

GlobalRPh-hosted RX List | Source revision: Revised July 2023
Linezolid; parent-drug renal guidance and dialysis timing.

Read this stored source

UCSF - linezolid: standard dose and optional expert reduction

UCSF Infectious Diseases Management Program | Source revision: Revision date not stated in the reviewed page.
Adults; source-specific institutional guidance. Match route, indication and renal replacement modality.

Read this stored source

Source difference identified; final patient-specific adjudication required. Added: vearlier.

Open / share source review Open drug and compare sources

guideline difference

Linezolid

Linezolid: qualified expert reduction versus label no-adjustment

UCSF describes an optional expert reduction for selected stable patients receiving a prolonged course, rather than a universal renal reduction. Its dialysis table remains separately stated.

What to reconcile

Document the source and qualifying clinical context; involve infectious diseases and consider drug-level monitoring. Do not apply the expert exception indiscriminately.

2 source identities and dates

GlobalRPh RX List - ZYVOX

GlobalRPh-hosted RX List | Source revision: Source revision date not established in selected retrieval.
Linezolid - ZYVOX renal label; selected renal source sections only, not a complete prescribing monograph.

Read this stored source

Linezolid - UCSF qualified renal guidance

University of California San Francisco, Infectious Diseases Management Program | Source revision: Source revision date not established in selected retrieval.
Linezolid - UCSF qualified renal guidance; selected renal source sections only, not a complete prescribing monograph.

Read this stored source

Source-specific interpretation; independent clinician adjudication pending. Added: v4.7.

Open / share source review Open drug and compare sources

source scope and renal guidance

Lisinopril

Before use: Lisinopril

Starting doses agree in selected sections; clinical context still controls titration.

What to reconcile

Distinguish initial dosing from maintenance; confirm formulation, indication, blood pressure, potassium and interacting medicines.

2 source identities and dates

GlobalRPh RX List - Zestril

GlobalRPh-hosted RX List | Source revision: Revision not established in selected sections
Adults; conventional oral lisinopril tablets, indication-specific starting doses.

Read this stored source

Lisinopril - conventional oral tablets

DailyMed / NLM exact product labeling | Source revision: 9/2021
Adults; conventional oral lisinopril tablets, indication-specific starting doses.

Read this stored source

Source-specific interpretation; independent clinician adjudication pending. Added: v6.3.

Open / share source review Open drug and compare sources

guideline difference

Lofexidine - LUCEMYRA

LUCEMYRA: a renal table does not cancel the chronic-renal-failure warning

The retrieved 2026 official label retains both a renal dosage table and an avoid-use warning for chronic renal failure. This is an unresolved within-label applicability tension, not evidence that either passage can be discarded.

What to reconcile

Do not use the table as automatic eligibility. Review the full warning, vital signs, ECG and specialist assessment; the RX mirror is not independent corroboration.

2 source identities and dates

GlobalRPh RX List - LUCEMYRA

GlobalRPh-hosted RX List | Source revision: RX page prints September 2020.
Lofexidine - LUCEMYRA; selected renal source sections only, not a complete prescribing monograph.

Read this stored source

Lofexidine - LUCEMYRA official label

DailyMed / BioCorRx Pharmaceuticals Inc | Source revision: Prescribing information revised 4/2026.
Lofexidine - LUCEMYRA official label; selected renal source sections only, not a complete prescribing monograph.

Read this stored source

Source-specific interpretation; independent clinician adjudication pending. Added: v4.7.

Open / share source review Open drug and compare sources

interaction scope

Lopinavir/ritonavir tablets (KALETRA)

The renal percentage reduction belongs to clarithromycin

The source includes CrCl-dependent clarithromycin reductions within KALETRA interaction guidance; its own renal PK statement is a separate observation.

What to reconcile

Identify which coadministered drug is being adjusted. Do not reduce KALETRA by the clarithromycin percentages.

1 source identities and dates

GlobalRPh RX List - KALETRA tablets

GlobalRPh-hosted RX List | Source revision: Source revision date not established in selected retrieval.
Oral KALETRA tablets; renal pharmacokinetics and separate clarithromycin interaction.

Read this stored source

Source-specific interpretation; independent clinician adjudication pending. Added: v4.2.

Open / share source review Open drug and compare sources

dialysis scope

Lumasiran - OXLUMO subcutaneous injection

OXLUMO: HD timing does not establish peritoneal dialysis evidence

The weight-based loading and maintenance phases have different intervals; peritoneal dialysis remains unstudied.

What to reconcile

Retain actual body weight, phase, first maintenance timing and post-HD administration.

1 source identities and dates

GlobalRPh RX List - OXLUMO

GlobalRPh-hosted RX List | Source revision: Source revision date not established in selected retrieval.
Lumasiran - OXLUMO subcutaneous injection; selected source sections only, not a complete prescribing monograph.

Read this stored source

Source-specific interpretation; independent clinician adjudication pending. Added: v4.9.

Open / share source review Open drug and compare sources

monitoring scope

Lutetium Lu 177 vipivotide tetraxetan - PLUVICTO

PLUVICTO: baseline renal dosing differs from treatment-emergent toxicity

The initial no-adjustment band does not replace the separate treatment-emergent toxicity pathway.

What to reconcile

Review the complete toxicity table before withholding, reducing or discontinuing; severe impairment and ESRD remain outside the selected evidence.

1 source identities and dates

GlobalRPh RX List - PLUVICTO

GlobalRPh-hosted RX List | Source revision: Source revision date not established in selected retrieval.
Lutetium Lu 177 vipivotide tetraxetan - PLUVICTO; selected renal passages, not a complete prescribing monograph.

Read this stored source

Source-specific interpretation; independent clinician adjudication pending. Added: v5.0.

Open / share source review Open drug and compare sources

formulation scope

Macitentan / tadalafil - OPSYNVI

OPSUMIT versus OPSYNVI: the combination changes renal restrictions

A macitentan pharmacokinetic statement does not establish eligibility for the macitentan/tadalafil combination.

What to reconcile

Check all ingredients and the combination-specific severe-impairment and dialysis restrictions.

1 source identities and dates

GlobalRPh RX List - OPSYNVI

GlobalRPh-hosted RX List | Source revision: RX page prints April 2025.
Macitentan / tadalafil - OPSYNVI; selected renal source sections only, not a complete prescribing monograph.

Read this stored source

Source-specific interpretation; independent clinician adjudication pending. Added: v4.7.

Open / share source review Open drug and compare sources Macitentan - OPSUMIT - related, not interchangeable

What is not established by this directory

Only documented issues are searchable here. Absence of a note is not agreement. A label mirror and the original label are not independent corroboration, and a source's retrieval date is not its revision date.

See source and A-Z review status Home / all drugs